Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Valabhji, J.
Right arrow Articles by Elkeles, R. S
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Dyslipidaemia in type 2 diabetes: epidemiology and biochemistry

Jonathan Valabhji

Department of Endocrinology and Metabolic Medicine, Imperial College School of Medicine, 1st Floor Mint Wing, St Marys Hospital, Praed Street, London, W2 1NY, UK, j.valabhji{at}ic.ac.uk

Robert S Elkeles

Lipid abnormalities in type 2 diabetes are characterised by high triglyceride concentrations, low high density lipoprotein-cholesterol concentrations, and normal total and low density lipoprotein-cholesterol (LDL-c) concentrations. LDL particles, however, are small and dense. Epidemiological evidence for these lipid abnormalities, and for the associations between lipid abnormalities and the increased risk of cardiovascular disease in type 2 diabetes, are presented. Most, of the lipid abnormalities in type 2 diabetes can be explained by reduced action of insulin at the tissue level. The biochemical and metabolic mechanisms underlying the lipid abnormalities are discussed.

Key Words: dyslipidaemia • type 2 diabetes • insulin action • cardiovascular disease.

References

  • Valabhji J., McColl A., Schachter M., Dhanjil S., Richmond W., Elkeles R. High-density lipoprotein composition and paraoxonase activity in type 1 diabetes. Clin Sci (Lond) 2001;101:659-70.[Medline] [Order article via Infotrieve]
  • DeFronzo RA Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988;37:667-87.[Web of Science][Medline] [Order article via Infotrieve]
  • Gu K., Cowie C., Harris M. Diabetes and decline in heart disease mortality in US adults. JAMA 1999;281:1291-7.[Abstract/Free Full Text]
  • Kannel W., McGee D. Diabetes and cardiovascular disease: the Framingham Study. JAMA 1979;241:2035-8.[Abstract/Free Full Text]
  • Manson J., Colditz G., Stamfer M. et al. A prospective study of maturity onset diabetes and risk of coronary heart disease and stroke in women. Arch Intern Med 1991;151:1141-7.[Abstract/Free Full Text]
  • Joslin E. Arteriosclerosis and diabetes. Ann Clin Med 1927;5:1061-79.
  • Allbrink M., May E. Serum triglycerides in health and diabetes. Diabetes 1958;7:154.
  • Barrett-Connor E., Grundy S., Holdbrook M. Plasma lipids and diabetes mellitus in an adult community. Am J Epidem 1982;115:657-63.[Abstract/Free Full Text]
  • Barrett-Connor E., Witztum JL, Holdbrook M. A community study of high density lipoproteins in adult non insulin-dependent diabetics. Am J Epidem 1983:117:186-92.[Abstract/Free Full Text]
  • Walden C., Knopp R., Wahl P., Beach K., Strandness E. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med 1984;311:953-9.[Abstract]
  • UK Prospective Diabetes Study Group. UKPDS 27. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex. Diabetes Care 1997;20:1683-7.[Abstract]
  • Barrett-Connor E., Cohn B., Wingard D., Edelstein S. Why is diabetes mellitus a stronger risk factor for fatal ischaemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991;265:627-31.[Abstract/Free Full Text]
  • Chen Y., Swami S., Skowronski R., Coulston A., Reaven G. Differences in post-prandial lipaemia between patients with normal glucose tolerance and non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1993;76:172-7.[Abstract]
  • Austin M., Breslow J., Hennekens C., Buring J., Willett W., Krauss R. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988;260:1917-21.[Abstract/Free Full Text]
  • Selby J., Austin M., Newman B. et al. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 1993;88:382-7.
  • Haffner S., Mykkanen L., Robbins D. et al. A preponderance of small dense LDL is associated with specific insulin, proinsulin and the insulin resistance syndrome. Diabetologia 1995;38:1328-36.[Web of Science][Medline] [Order article via Infotrieve]
  • Austin M., Mykkanen L., Kuusisto J. et al. Prospective study of small LDLs as a risk factor for D non-insulin dependent diabetes mellitus in elderly men and women. Circulation 1995;92:1770-8.[Abstract/Free Full Text]
  • Zoratti R. A review on ethnic differences in plasma triglycerides and highdensity-lipoprotein cholesterol: is the lipid pattern the key factor for the low coronary heat disease rate in people of African origin? Eur J Epidemiol 1998; 14:9-21.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Chaturvedi N., Jarrett J., Morrish N., Keen H., Fuller J. Differences in mortality and morbidity in African Caribbean and European people with noninsulin dependent diabetes mellitus: results of 20 year follow up of a London cohort of a multinational study. BMJ 1996;313:848-52.[Abstract/Free Full Text]
  • Santen R., Willis P., Fajans S. Atherosclerosis in diabetes mellitus Correlations with serum lipids levels, adiposity and serum insulin level. Arch Intern Med 1972;130:833-43.[Abstract/Free Full Text]
  • Reckless J., Betteridge D., Wu P., Payne B., Galton D. High density and low density lipoproteins and prevalence of vascular disease in diabetes mellitus. BMJ 1978;1:883-6.[Abstract/Free Full Text]
  • Seviour P., Teal T., Richmond W., Elkeles R. Serum lipids, lipoproteins and macrovascular disease in non-insulin dependent diabetics: a possible new approach to prevention. Diabet Med 1988;5:166-71.[Web of Science][Medline] [Order article via Infotrieve]
  • Laakso M., Lehto S., Penttila I., Pyorala K. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin dependent diabetes. Circulation 1993;88:1421-30.[Abstract/Free Full Text]
  • Uusitupa M., Niskanen L., Siitonen O., Voutilainen E., Pyorala K. Ten year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 diabetic and non-diabetic subjects. Diabetologia 1993;36:1175-84.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Turner R., Millns H., Neil H. et al. Risk factors for coronary artery disease in non-insulin dependent diabetes: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998;316:823-8.[Abstract/Free Full Text]
  • Sacks F., Tonkin A., Craven T. et al. Coronary heart disease in Patients with low LDL-cholesterol: Benefit of pravastatin in diabetics and enhanced role for HDL cholesterol and triglycerides as risk factors. Circulation 2002; 105:1424-8.[Abstract/Free Full Text]
  • Syvanne M., Pajunen P., Kahn J. et al. Determinants of the severity and extent of coronary artery disease in patients with type 2 diabetes and in non-diabetic subjects. Coron Artery Dis 2001;12:99-106.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lu W., Resnick H., Jablonski K. et al. Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: The Strong Heart Study. Diabetes Care 2003;26:16-23.[Abstract/Free Full Text]
  • Haffner S., Stern M., Hazuda H., Mitchell B., Patterson J. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990;263:2893-8.[Abstract/Free Full Text]
  • Howard B. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987; 28:613-28.[Web of Science][Medline] [Order article via Infotrieve]
  • Despres J-P., Couillard C., Gagnon J. et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: The health, risk factors, exercise training, and genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol 2000;20:1932-8.[Abstract/Free Full Text]
  • Zoratti R., Godsland I., Chaturvedi N., Crook D., Stevenson J., McKeigue P. Relation of plasma lipids to insulin resistance, non-esterified fatty acid levels and body fat in men from three ethnic groups: relevance to variation in risk of diabetes and coronary disease. Metabolism 2000;49:245-52.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Malmström R., Packard C., Watson T. et al. Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol 1997;17:1454-64.[Abstract/Free Full Text]
  • Goldberg U. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 1996;37:693-707.[Abstract]
  • Greenwood M. The relationship of enzyme activity to feeding behavior in rats: lipoprotein lipase as the metabolic gatekeeper. Int J Obes 1985;9:67-70.[Medline] [Order article via Infotrieve]
  • Brinton EA, Eisenberg S., Breslow JL Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women. J Clin Invest 1989;84:262-9.[Web of Science][Medline] [Order article via Infotrieve]
  • Brinton EA, Eisenberg S., Breslow JL Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridaemia. J Clin Invest 1991; 87:536-44.[Web of Science][Medline] [Order article via Infotrieve]
  • Le A-G., Ginsberg HN Heterogeneity of apolipoprotein A-I turnover in subjects with reduced concentrations of plasma high density lipoprotein cholesterol. Metabolism 1988;37:614-17.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Mann CJ, Yen FT, Grant AM, Bihain BE Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 1991;88:2059-66.[Web of Science][Medline] [Order article via Infotrieve]
  • Patsch J., Prasad S., Gotto A., Bengtsson-Olivecrona G. Postprandial lipaemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase. J Clin Invest 1984;74:2017-23.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Packard C., Shepherd J. Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol 1997;17:3542-56.[Abstract/Free Full Text]
  • Jeffs JAR, Godsland IF, Johnston DG The majority of variation in HDL cholesterol is not explained by conventional determinants in cross-sectional and longitudinal studies. Diabet Med 2003;20(suppl 2):48.
  • Wang N., Silver DL, Costet P., Tall AR Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem 2000;275:33053-8.[Abstract/Free Full Text]
  • Bortnick AE, Rothblat GH, Stoudt G. et al. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J Biol Chem 2000;275:28634-40.[Abstract/Free Full Text]
  • Oram JF, Lawn RM, Garvin MR, Wade DP ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J Biol Chem 2000;275:34508-11.[Abstract/Free Full Text]
  • Brooks Wilson A., Marcil M., Clee SM et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999; 22:336-45.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bodzioch M., Orso E., Klucken J. et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 1999;22: 347-51.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Rust S., Rosier M., Funke H. et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 1999;22:352-5.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Tu A-Y., Albers J. Glucose regulates the transcription of human genes relevant to HDL metabolism: responsive elements for peroxisome proliferator-activated receptor are involved in the regulation of phospholipid transfer protein. Diabetes 2001;50:1851-6.[Abstract/Free Full Text]

The British Journal of Diabetes & Vascular Disease, Vol. 3, No. 3, 184-189 (2003)
DOI: 10.1177/14746514030030030501
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Valabhji, J.
Right arrow Articles by Elkeles, R. S
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?